Information campaigns to increase vaccine uptake

Last registered on December 14, 2020
View Trial History

Pre-Trial

Trial Information

General Information

Title
Information campaigns to increase vaccine uptake
RCT ID
AEARCTR-0006885
Initial registration date
December 11, 2020

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
December 14, 2020, 10:32 AM EST

First published corresponds to when the trial was first made public on the Registry after being reviewed.

Locations

Country
United States of America
Region
Wyoming

Primary Investigator

Name
Madison Ashworth
Affiliation
Fletcher Group, Inc.
Contact Primary Investigator

Other Primary Investigator(s)

PI Name
David Finnoff
PI Affiliation
University of Wyoming
Contact Investigator
PI Name
Todd Cherry
PI Affiliation
University of Wyoming
Contact Investigator
PI Name
Stephen Newbold
PI Affiliation
University of Wyoming
Contact Investigator
PI Name
Linda Thunstrom
PI Affiliation
University of Wyoming
Contact Investigator

Additional Trial Information

Status
In development
Start date
2020-12-11
End date
2021-01-01
Keywords
Behavior, Health
Additional Keywords
JEL code(s)
Secondary IDs
Abstract
The goal of this study is to determine how information campaigns that explain different benefits of widespread vaccination against COVID-19 affect vaccine uptake. We will conduct a survey experiment where participants will be exposed to 1 of 9 different information treatments including: a no information, control treatment, information explaining the economic benefits of taking the COVID-19 vaccine, the public health benefits of widespread vaccination against COVID-19, the private health benefits of vaccinating against COVID-19, and combinations of private health benefit, public health benefit, and economic benefit messages, and the vaccine trial process.
External Link(s)

Registration Citation

Citation
Ashworth, Madison et al. 2020. "Information campaigns to increase vaccine uptake." AEA RCT Registry. December 14. https://doi.org/10.1257/rct.6885-1.0
Sponsors & Partners
Experimental Details

Interventions

Intervention(s)
We will conduct a survey experiment where participants will be exposed to 1 of 9 different information treatments including: a no information, control treatment, information explaining the economic benefits of taking the COVID-19 vaccine, the public health benefits of widespread vaccination against COVID-19, the private health benefits of vaccinating against COVID-19, and combinations of private health benefit, public health benefit, and economic benefit messages, and the vaccine trial process.
Intervention Start Date
2020-12-11
Intervention End Date
2021-01-01

Primary Outcomes

Primary Outcomes (end points)
The proportion of the population that will take the vaccine when it first becomes available.
Primary Outcomes (explanation)

Secondary Outcomes

Secondary Outcomes (end points)
Secondary Outcomes (explanation)

Experimental Design

Experimental Design
Participants will be randomized into 1 of 9 different information treatments where they will be informed of the private health benefits of vaccination, the public health benefits of vaccination, the economic benefits of vaccination, a combination of private, public and economic benefits, or the vaccine trial process. Participants will then be asked about their willingness to take a COVID-19 vaccine. In the second part of the survey, participants will be asked about how they have been affected most by the pandemic, what they worry about most, the extent they are complying with social distancing and mask wearing, and how disruptive the pandemic has been in terms of health and employment.
Experimental Design Details
Participants will be randomized into 1 of 9 different information treatments where they will be informed of the private health benefits of vaccination, the public health benefits of vaccination, the economic benefits of vaccination, a combination of private, public and economic benefits, or the vaccine trial process. Participants will then be asked about their willingness to take a COVID-19 vaccine. In the second part of the survey, participants will be asked about how they have been affected most by the pandemic, what they worry about most, the extent they are complying with social distancing and mask wearing, and how disruptive the pandemic has been in terms of health and employment.
Randomization Method
by a computer
Randomization Unit
Individual
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
0
Sample size: planned number of observations
3000
Sample size (or number of clusters) by treatment arms
333
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
Supporting Documents and Materials
IRB

Institutional Review Boards (IRBs)

IRB Name
University of Wyoming Institutional Review Board
IRB Approval Date
2020-12-07
IRB Approval Number
N/A
Analysis Plan

Post-Trial

Post Trial Information

Study Withdrawal

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Intervention

Is the intervention completed?
No
Data Collection Complete
Data Publication

Data Publication

Is public data available?
No

Program Files

Program Files
Reports, Papers & Other Materials

Relevant Paper(s)

Reports & Other Materials